The benefits and costs of U.S. employer COVID-19 vaccine mandates.
Ferranna M, Robinson LA, Cadarette D, Eber MR, Bloom DE.
Risk Anal. 2023 10. 43(10):2053-2068. PMID: 36649917
Deputy Director, Center for Health Decision Science
Center for Health Decision Science
Harvard T.H. Chan School of Public Health
Lisa A. Robinson’s research and teaching focus on the conduct of benefit-cost analysis, particularly for policies with outcomes that cannot be fully valued using market measures. She has led numerous assessments of the costs, benefits, and other impacts of environmental, health, and safety policies and regulations, developed related methods, and drafted guidance documents. She co-edited the National Academies book, "Valuing Health for Regulatory Cost-Effectiveness Analysis," led the creation of guidelines for benefit-cost analysis of U.S. Department of Health and Human Services regulations and of global health interventions, and developed approaches for estimating the value of mortality risk reductions (the value per statistical life, VSL) for several government agencies and other organizations. She has explored numerous other methodological issues, including the implications of behavioral economics and happiness (subjective wellbeing) research for benefit-cost analysis, approaches for addressing the distribution of impacts across advantaged and disadvantaged groups, and the ethical concerns. She applies these methods in high-, middle-, and low-income settings. Her work addresses a variety of policy issues, including responses to vaccine mandates and to hazard warnings. She is currently reviewing methods for assessing the benefits of air pollution policies as a member of the U.S. Environmental Protection Agency’s Science Advisory Board BenMAP and Benefits Methods Panel.
Ms. Robinson is currently Deputy Director of the Center for Health Decision Science and affiliated with the Harvard Center for Risk Analysis. She was previously a Senior Fellow at the Mossavar-Rahmani Center for Business and Government as well as an Affiliate Fellow of its Regulatory Policy Program at the Harvard Kennedy School. She is a past President of the Society for Benefit-Cost Analysis and served as a Councilor of the Society for Risk Analysis as well as Chair of its Economics and Benefits Analysis Specialty Group. She is on the Editorial Boards of Risk Analysis and the Journal of Benefit-Cost Analysis.
For related publications, see: https://www.hsph.harvard.edu/lisa-robinson/publications/
BA, 1979, Political Science/International Relations
Carleton College, Northfield MN
MPP, 1982, Public Policy
Harvard Kennedy School, Cambridge MA
Fellow, Society for Benefit-Cost Analysis
Society for Benefit-Cost Analysis
Outstanding Practitioner Award, Society for Risk Analysis
Society for Risk Analysis
Best Symposium Award, Journal of Benefit-Cost Analysis
Journal of Benefit-Cost Analysis
Fellow, Society for Risk Analysis
Society for Risk Analysis
Richard O. Zerbe Distinguished Service Award, Society for Benefit-Cost Analysis
Society for Benefit-Cost Analysis
Richard J. Burk Outstanding Service Award, Society for Risk Analysis
Society for Risk Analysis
Ferranna M, Robinson LA, Cadarette D, Eber MR, Bloom DE.
Risk Anal. 2023 10. 43(10):2053-2068. PMID: 36649917
Robinson LA, Eber MR, Hammitt JK.
J Benefit Cost Anal. 2022. 13(2):247-268. PMID: 36090595
Hammitt JK, Robinson LA.
Risk Anal. 2021 04. 41(4):559-564. PMID: 33843076
Buonocore JJ, Robinson LA, Hammitt JK, O'Keeffe L.
Risk Anal. 2021 04. 41(4):645-660. PMID: 33249613
Robinson LA, Sullivan R, Shogren JF.
Risk Anal. 2021 05. 41(5):761-770. PMID: 32677076
Robinson LA, Hammitt JK, Jamison DT, Walker DG.
J Benefit Cost Anal. 2019. 10(Suppl 1):1-14. PMID: 33282627
Robinson LA, Hammitt JK, O'Keeffe L.
J Benefit Cost Anal. 2019. 10(Suppl 1):15-50. PMID: 32968616
Robinson, L.A., W.J. Raich, J.K. Hammitt, and L. O’Keeffe.
Journal of Benefit-Cost Analysis. 2019. 2(10):156-177.
Chang AY, Robinson LA, Hammitt JK, Resch SC.
J Glob Health. 2017 Jun. 7(1):010401. PMID: 28400950
Robinson, L.A.
Journal of Benefit-Cost Analysis. 2017. 1(7):1-11.
Experts discussed solutions for dealing with the health impacts of climate change-driven extreme heat at a panel during the Harvard Climate Symposium.
Next-generation vaccines and air filtration are among the most important areas to invest in to tame the pandemic going forward, according to experts.
Experts quoted in a January 23, 2022 CNN article talked about why humans do a poor job of evaluating climate risk, how they tend to avoid an overload of distressing information, and how it’s crucial to better communicate…
Lisa Robinson of the Center for Health Decision Science has been exploring the complexities involved in valuing deaths averted by COVID-19 policies.
The reasons why some people don’t wear masks to protect themselves from COVID-19 and engage in other risky behaviors, including attending large gatherings, are complex and due to a number of factors, according to news reports. A November…